205 related articles for article (PubMed ID: 17352358)
1. Mechanisms of action of IVIG in adult onset Rasmussen's encephalitis.
Buenz EJ; Howe CL
Can J Neurol Sci; 2007 Feb; 34(1):108-9. PubMed ID: 17352358
[No Abstract] [Full Text] [Related]
2. Genetics of childhood disorders: XXX. Autoimmune disorders, part 3: myasthenia gravis and Rasmussen's encephalitis.
Lombroso PJ; Mercadante MT
J Am Acad Child Adolesc Psychiatry; 2001 Sep; 40(9):1115-7. PubMed ID: 11556637
[No Abstract] [Full Text] [Related]
3. Rasmussen's syndrome.
Granata T
Neurol Sci; 2003 Oct; 24 Suppl 4():S239-43. PubMed ID: 14598051
[TBL] [Abstract][Full Text] [Related]
4. Autoantibodies to glutamate receptor GluR3 in Rasmussen's encephalitis.
Rogers SW; Andrews PI; Gahring LC; Whisenand T; Cauley K; Crain B; Hughes TE; Heinemann SF; McNamara JO
Science; 1994 Jul; 265(5172):648-51. PubMed ID: 8036512
[TBL] [Abstract][Full Text] [Related]
5. High-dose intravenous immunoglobulin G treatment of myasthenia gravis.
Ferrero B; Durelli L
Neurol Sci; 2002 Apr; 23 Suppl 1():S9-24. PubMed ID: 12032583
[TBL] [Abstract][Full Text] [Related]
6. Autoantibodies and cell-mediated autoimmunity to NMDA-type GluRepsilon2 in patients with Rasmussen's encephalitis and chronic progressive epilepsia partialis continua.
Takahashi Y; Mori H; Mishina M; Watanabe M; Kondo N; Shimomura J; Kubota Y; Matsuda K; Fukushima K; Shiroma N; Akasaka N; Nishida H; Imamura A; Watanabe H; Sugiyama N; Ikezawa M; Fujiwara T
Epilepsia; 2005; 46 Suppl 5():152-8. PubMed ID: 15987271
[TBL] [Abstract][Full Text] [Related]
7. Long-term effect of intravenous immunoglobulin on anti-MuSK antibody-positive myasthenia gravis.
Shibata-Hamaguchi A; Samuraki M; Furui E; Iwasa K; Yoshikawa H; Hayashi S; Yamada M
Acta Neurol Scand; 2007 Dec; 116(6):406-8. PubMed ID: 17986100
[TBL] [Abstract][Full Text] [Related]
8. Late-onset Rasmussen's encephalitis and long-term remission.
Kupila L; Jutila L; Immonen A; Vanninen R; Mervaala E; Pateau A; Luostarinen L; Kälviäinen R
Epileptic Disord; 2011 Mar; 13(1):88-91. PubMed ID: 21393098
[TBL] [Abstract][Full Text] [Related]
9. Improvement with rituximab in a patient with both rheumatoid arthritis and myasthenia gravis.
Kerkeni S; Marotte H; Miossec P
Muscle Nerve; 2008 Oct; 38(4):1343-5. PubMed ID: 18816604
[No Abstract] [Full Text] [Related]
10. Treatment of myasthenia gravis acute exacerbations with intravenous immunoglobulin.
Gajdos P; Chevret S
Ann N Y Acad Sci; 2008; 1132():271-5. PubMed ID: 18096850
[TBL] [Abstract][Full Text] [Related]
11. IVIG treatment for myasthenia gravis: effectiveness, limitations, and novel therapeutic strategies.
Zinman L; Bril V
Ann N Y Acad Sci; 2008; 1132():264-70. PubMed ID: 18567877
[TBL] [Abstract][Full Text] [Related]
12. Rasmussen's encephalitis in a 58-year-old female: still a variant?
Hunter GR; Donat J; Pryse-Phillips W; Harder S; Robinson CA
Can J Neurol Sci; 2006 Aug; 33(3):302-5. PubMed ID: 17001818
[TBL] [Abstract][Full Text] [Related]
13. Chronic steroid-responsive encephalitis without autoantibodies to glutamate receptor GluR3.
Krauss GL; Campbell ML; Roche KW; Huganir RL; Niedermeyer E
Neurology; 1996 Jan; 46(1):247-9. PubMed ID: 8559386
[TBL] [Abstract][Full Text] [Related]
14. Good outcome in adult-onset Rasmussen's encephalitis syndrome: is recovery possible?
Poloni TE; Galli A; Pichiecchio A; di Lodovico L; Ceroni M
Epileptic Disord; 2015 Jun; 17(2):204-8. PubMed ID: 25906060
[TBL] [Abstract][Full Text] [Related]
15. A disease-specific fraction isolated from IVIG is essential for the immunosuppressive effect of IVIG in experimental autoimmune myasthenia gravis.
Fuchs S; Feferman T; Meidler R; Margalit R; Sicsic C; Wang N; Zhu KY; Brenner T; Laub O; Souroujon MC
J Neuroimmunol; 2008 Feb; 194(1-2):89-96. PubMed ID: 18178258
[TBL] [Abstract][Full Text] [Related]
16. Antibodies against GluR3 peptides are not specific for Rasmussen's encephalitis but are also present in epilepsy patients with severe, early onset disease and intractable seizures.
Mantegazza R; Bernasconi P; Baggi F; Spreafico R; Ragona F; Antozzi C; Bernardi G; Granata T
J Neuroimmunol; 2002 Oct; 131(1-2):179-85. PubMed ID: 12458050
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic antibodies in multiple sclerosis.
Goebels N; Becher B
Neurodegener Dis; 2008; 5(1):5-7. PubMed ID: 18075268
[No Abstract] [Full Text] [Related]
18. [THE ROLE OF AUTOANTIBODIES TO THE EXTRACELLULAR REGIONS OF IONOTROPIC RECEPTORS IN ETIOLOGY AND PATHOGENESIS OF AUTOIMMUNE DISEASES].
Zharova OA; Shpakov AO
Ross Fiziol Zh Im I M Sechenova; 2016 Jul; 102(7):773-91. PubMed ID: 30193046
[TBL] [Abstract][Full Text] [Related]
19. Autoantibodies to glutamate receptor antigens in multiple sclerosis and Rasmussen's encephalitis.
Trippe J; Steinke K; Orth A; Faustmann PM; Hollmann M; Haase CG
Neuroimmunomodulation; 2014; 21(4):189-94. PubMed ID: 24504116
[TBL] [Abstract][Full Text] [Related]
20. Thymoma, myasthenia gravis, encephalitis, and a novel anticytoplasmic neuronal antibody.
Khella SL; Souyah N; Dalmau J
Neurology; 2007 Sep; 69(12):1302-3. PubMed ID: 17875920
[No Abstract] [Full Text] [Related]
[Next] [New Search]
